vs
晨星（MORN）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
晨星的季度营收约是Royalty Pharma plc的1.0倍（$644.8M vs $622.0M），晨星同比增速更快（10.8% vs 4.8%），过去两年晨星的营收复合增速更高（6.2% vs 4.6%）
晨星（Morningstar, Inc.）是总部位于美国伊利诺伊州芝加哥的金融服务机构，由乔·曼苏托于1984年创立，面向全球提供全方位的投资研究、投资管理等专业服务，是全球颇具知名度的投资资讯服务提供商。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
MORN vs RPRX — 直观对比
营收规模更大
MORN
是对方的1.0倍
$622.0M
营收增速更快
MORN
高出6.0%
4.8%
两年增速更快
MORN
近两年复合增速
4.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $644.8M | $622.0M |
| 净利润 | — | $214.2M |
| 毛利率 | 62.9% | — |
| 营业利润率 | 24.2% | 62.4% |
| 净利率 | — | 34.4% |
| 营收同比 | 10.8% | 4.8% |
| 净利润同比 | — | 2.9% |
| 每股收益（稀释后） | $2.73 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MORNRPRX
| Q1 26 | $644.8M | — | ||
| Q4 25 | $641.1M | $622.0M | ||
| Q3 25 | $617.4M | $609.3M | ||
| Q2 25 | $605.1M | $578.7M | ||
| Q1 25 | $581.9M | $568.2M | ||
| Q4 24 | $591.0M | $593.6M | ||
| Q3 24 | $569.4M | $564.7M | ||
| Q2 24 | $571.9M | $537.3M |
净利润MORNRPRX
| Q1 26 | — | — | ||
| Q4 25 | $115.1M | $214.2M | ||
| Q3 25 | $91.6M | $288.2M | ||
| Q2 25 | $89.0M | $30.2M | ||
| Q1 25 | $78.5M | $238.3M | ||
| Q4 24 | $116.9M | $208.2M | ||
| Q3 24 | $119.7M | $544.0M | ||
| Q2 24 | $69.1M | $102.0M |
毛利率MORNRPRX
| Q1 26 | 62.9% | — | ||
| Q4 25 | 61.1% | — | ||
| Q3 25 | 60.9% | — | ||
| Q2 25 | 61.9% | — | ||
| Q1 25 | 60.2% | — | ||
| Q4 24 | 60.7% | — | ||
| Q3 24 | 60.9% | — | ||
| Q2 24 | 61.1% | — |
营业利润率MORNRPRX
| Q1 26 | 24.2% | — | ||
| Q4 25 | 24.9% | 62.4% | ||
| Q3 25 | 20.7% | 70.1% | ||
| Q2 25 | 20.7% | 36.3% | ||
| Q1 25 | 19.6% | 94.0% | ||
| Q4 24 | 28.5% | 60.9% | ||
| Q3 24 | 20.3% | — | ||
| Q2 24 | 19.0% | 50.2% |
净利率MORNRPRX
| Q1 26 | — | — | ||
| Q4 25 | 18.0% | 34.4% | ||
| Q3 25 | 14.8% | 47.3% | ||
| Q2 25 | 14.7% | 5.2% | ||
| Q1 25 | 13.5% | 41.9% | ||
| Q4 24 | 19.8% | 35.1% | ||
| Q3 24 | 21.0% | 96.3% | ||
| Q2 24 | 12.1% | 19.0% |
每股收益（稀释后）MORNRPRX
| Q1 26 | $2.73 | — | ||
| Q4 25 | $2.79 | $0.49 | ||
| Q3 25 | $2.17 | $0.67 | ||
| Q2 25 | $2.09 | $0.07 | ||
| Q1 25 | $1.82 | $0.55 | ||
| Q4 24 | $2.72 | $0.46 | ||
| Q3 24 | $2.77 | $1.21 | ||
| Q2 24 | $1.60 | $0.23 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $492.8M | $618.7M |
| 总债务越低越好 | $1.7B | $9.0B |
| 股东权益账面价值 | $1.0B | $9.7B |
| 总资产 | $4.0B | $19.6B |
| 负债/权益比越低杠杆越低 | 1.68× | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资MORNRPRX
| Q1 26 | $492.8M | — | ||
| Q4 25 | $528.7M | $618.7M | ||
| Q3 25 | $40.3M | $938.9M | ||
| Q2 25 | $38.1M | $631.9M | ||
| Q1 25 | $47.7M | $1.1B | ||
| Q4 24 | $551.0M | $929.0M | ||
| Q3 24 | $48.8M | $950.1M | ||
| Q2 24 | $48.0M | $1.8B |
总债务MORNRPRX
| Q1 26 | $1.7B | — | ||
| Q4 25 | — | $9.0B | ||
| Q3 25 | $848.9M | $8.9B | ||
| Q2 25 | $838.8M | $8.0B | ||
| Q1 25 | $803.7M | $7.6B | ||
| Q4 24 | $698.6M | $7.6B | ||
| Q3 24 | $864.7M | $7.6B | ||
| Q2 24 | $899.6M | $7.6B |
股东权益MORNRPRX
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.2B | $9.7B | ||
| Q3 25 | $1.5B | $9.6B | ||
| Q2 25 | $1.6B | $9.5B | ||
| Q1 25 | $1.6B | $9.8B | ||
| Q4 24 | $1.6B | $10.3B | ||
| Q3 24 | $1.6B | $10.3B | ||
| Q2 24 | $1.4B | $9.8B |
总资产MORNRPRX
| Q1 26 | $4.0B | — | ||
| Q4 25 | $3.6B | $19.6B | ||
| Q3 25 | $3.6B | $19.3B | ||
| Q2 25 | $3.6B | $18.3B | ||
| Q1 25 | $3.6B | $17.6B | ||
| Q4 24 | $3.5B | $18.2B | ||
| Q3 24 | $3.6B | $18.0B | ||
| Q2 24 | $3.4B | $17.7B |
负债/权益比MORNRPRX
| Q1 26 | 1.68× | — | ||
| Q4 25 | — | 0.92× | ||
| Q3 25 | 0.56× | 0.93× | ||
| Q2 25 | 0.52× | 0.84× | ||
| Q1 25 | 0.50× | 0.78× | ||
| Q4 24 | 0.43× | 0.74× | ||
| Q3 24 | 0.55× | 0.74× | ||
| Q2 24 | 0.63× | 0.78× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $53.6M | — |
| 自由现金流率自由现金流/营收 | 8.3% | — |
| 资本支出强度资本支出/营收 | 5.9% | — |
| 现金转化率经营现金流/净利润 | — | 3.86× |
| 过去12个月自由现金流最近4个季度 | $437.4M | — |
8季度趋势，按日历期对齐
经营现金流MORNRPRX
| Q1 26 | — | — | ||
| Q4 25 | $204.0M | $827.1M | ||
| Q3 25 | $195.7M | $702.6M | ||
| Q2 25 | $99.0M | $364.0M | ||
| Q1 25 | $91.0M | $596.1M | ||
| Q4 24 | $153.4M | $742.5M | ||
| Q3 24 | $191.9M | $703.6M | ||
| Q2 24 | $152.7M | $658.2M |
自由现金流MORNRPRX
| Q1 26 | $53.6M | — | ||
| Q4 25 | $161.3M | — | ||
| Q3 25 | $160.1M | — | ||
| Q2 25 | $62.4M | — | ||
| Q1 25 | $58.8M | — | ||
| Q4 24 | $112.8M | — | ||
| Q3 24 | $155.8M | — | ||
| Q2 24 | $120.8M | — |
自由现金流率MORNRPRX
| Q1 26 | 8.3% | — | ||
| Q4 25 | 25.2% | — | ||
| Q3 25 | 25.9% | — | ||
| Q2 25 | 10.3% | — | ||
| Q1 25 | 10.1% | — | ||
| Q4 24 | 19.1% | — | ||
| Q3 24 | 27.4% | — | ||
| Q2 24 | 21.1% | — |
资本支出强度MORNRPRX
| Q1 26 | 5.9% | — | ||
| Q4 25 | 6.7% | — | ||
| Q3 25 | 5.8% | — | ||
| Q2 25 | 6.0% | — | ||
| Q1 25 | 5.5% | — | ||
| Q4 24 | 6.9% | — | ||
| Q3 24 | 6.3% | — | ||
| Q2 24 | 5.6% | — |
现金转化率MORNRPRX
| Q1 26 | — | — | ||
| Q4 25 | 1.77× | 3.86× | ||
| Q3 25 | 2.14× | 2.44× | ||
| Q2 25 | 1.11× | 12.06× | ||
| Q1 25 | 1.16× | 2.50× | ||
| Q4 24 | 1.31× | 3.57× | ||
| Q3 24 | 1.60× | 1.29× | ||
| Q2 24 | 2.21× | 6.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MORN
暂无分部数据
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
